Aerovate Therapeutics Stock Quote AVTE - Stock Price, News, Charts, Message Board, Trades

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

21.04

Bid

8.40

Ask

32.99

Volume

137,134

19.81 Day's Range 21.20

0.00 52 Week Range 0.00

Market Cap

582.707M

Previous Close

20.44

Open

20.19

Last Trade

678

21.04

(priorref)

Last Trade Time

Financial Volume

$ 2,832,002

VWAP

20.6513

Average Volume (3m)

Shares Outstanding

27,668,887

Dividend Yield

PE Ratio

-7.72

Earnings Per Share (EPS)

-2.73

Revenue

Net Profit

-75.52M

Aerovate Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing drugs that improve the lives of patients with rare cardiopulmonary disease. Its initial focus is on advancing AV-101, dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hyper... Aerovate Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing drugs that improve the lives of patients with rare cardiopulmonary disease. Its initial focus is on advancing AV-101, dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension, a devastating disease impacting people in the United States and Europe. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.aerovatetx.com

Headquarters

Wilmington, Delaware, USA

Founded

1970

Aerovate Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker AVTE. The last closing price for Aerovate Therapeutics was $20.44. Over the last year, Aerovate Therapeutics shares have traded in a share price range of $ 0.00 to $ 0.00.

Aerovate Therapeutics currently has 27,668,887 shares outstanding. The market capitalization of Aerovate Therapeutics is $582.71 million. Aerovate Therapeutics has a price to earnings ratio (PE ratio) of -7.72.

Aerovate Therapeutics to Present Patient Baseline Characteristics of the Phase 2b Portion of the Phase 2b/Phase 3 IMPAHCT Trial at the American Thoracic Society 2024 International Conference

WALTHAM, Mass., March 27, 2024 (GLOBE NEWSWIRE) -- Aerovate Therapeutics, Inc. (Nasdaq: AVTE), a clinical stage biopharmaceutical company focused on developing drugs that improve the lives of...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
REBNReborn Coffee Inc	$ 3.14 (81.50%)	109.96M
SGDSafe and Green Development Corporation	$ 0.62 (58.81%)	70.08M
INODInnodata Inc	$ 10.50 (55.44%)	19.16M
ISUNiSun Inc	$ 0.1958 (48.33%)	135.23M
CRCTCricut Inc	$ 8.16 (47.56%)	7.86M
TMCITreace Medical Concepts Inc	$ 4.19 (-62.32%)	15.64M
MCRBSeres Therapeutics Inc	$ 0.74 (-33.33%)	15.05M
TOIIWOncology Institute Inc	$ 0.1168 (-32.09%)	122.56k
TRIPTripAdvisor Inc	$ 18.16 (-28.73%)	27.68M
SIGASIGA Technologies Inc	$ 7.50 (-28.30%)	4.17M
ISUNiSun Inc	$ 0.1958 (48.33%)	135.23M
REBNReborn Coffee Inc	$ 3.14 (81.50%)	109.96M
SQQQProShares UltraPro Short QQQ	$ 10.74 (0.19%)	100.71M
NKLANikola Corporation	$ 0.5791 (-3.95%)	85.64M
FCELFuelCell Energy Inc	$ 0.76 (-3.74%)	84.39M